0001214659-22-000735.txt : 20220114 0001214659-22-000735.hdr.sgml : 20220114 20220114170603 ACCESSION NUMBER: 0001214659-22-000735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220112 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORRIS TIMOTHY E CENTRAL INDEX KEY: 0001191286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 22532588 MAIL ADDRESS: STREET 1: ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-55061.xml PRIMARY DOCUMENT X0306 4 2022-01-12 0001293310 HUMANIGEN, INC HGEN 0001191286 MORRIS TIMOTHY E C/O HUMANIGEN, INC. 533 AIRPORT BOULEVARD, SUITE 400 BURLINGAME CA 94010 false true false false COO and CFO Stock Option (Right to Buy) 2.99 2022-01-12 4 A false 59841 0 A 2023-01-12 2032-01-11 Common Stock 59841 59841 D The stock option was granted to the Reporting Person at the direction of the Company in satisfaction of amounts earned under the Company's 2021 annual incentive plan. /s/ Timothy Morris 2022-01-14